News About: Pharm. Industry
Hanmi holds third symposium for Amosartan
Hanmi Pharmaceutical Co. said that it has successfully completed its nationwide symposium for Amosartan, hypertension combination drug combination drug of amlodipine camsylate and losartan potassium, between May 22 an...
Neodin builds up-dated lab automation system
Neodin Medical Institute (NMI), a local laboratory test service provider for clinics, hospitals and research centers nationwide, announced Monday that it has signed a contract with Roche Diagnostics Korea to build its...
Drug makers seek allies to brace for gov’t price cuts
To prepare for government-mandated cuts in drug prices in April, more and more local drug makers are teaming up with bioventure firms and universities for joint tech development. For pharmaceutical companies that lack...
KDRA, FEBPS forge partnership
The Korea Drug Research Association announced recently that it has inked a memorandum of understanding (MOU) with the FEBPS (Foreign Experienced Korean Biotech/Pharmaceutical Societies), a private organization compris...
13 household medicines to be available at convenience stores from November
The Ministry of Health and Welfare announced Thursday that 13 over-the-counter (OTC) drugs will be sold at 24-hour convenience stores from November 15.
The selected items are as follows:
1) Antipyretics and analge...
Handok forges strategic tie-up with Roche Korea
Handok Pharmaceutical said Wednesday that it has forged a strategic alliance with Roche Korea in an effort to strengthen its domestic competitiveness.
Under the deal, Handok will be in charge of selling Roche drug ...
Dong-A to roll out Panpyrin tablets
Dong-A Pharmaceutical Co. will release its renowned painkiller ‘Pampyrin’ tablets from next week, along with its drink dosage form, in its latest move to take a bigger share in the domestic market.
The introduction...
10 drug makers urged to settle returned medicine issue
Pharmaceutical wholesalers on Tuesday announced a list of ten drug makers, including Daewoong Pharmaceutical and JW Pharmaceutical, who failed to settle the price difference of medicines returned to them during the fi...
Combo pills perk up firms’ profits
It has become more common for patients with blood sugar problems and high blood pressure to treat both ills with one pill a day – a more convenient way to manage multiple medications, particularly for the elderly.
...
KHSA to have dominant say in local foods industry
The Korea Health Supplements Association (KHSA) will have a dominant say in the domestic health in health functional food industry as a major business lobby group as large food makers are willing to join the associati...
